Oxidative Folding of Proteins in Escherichia Coli - The author highlights novel strains and methods that have recently been shown to express multidisulfide bonded proteins. This article is part of a s

ADVERTISEMENT

Oxidative Folding of Proteins in Escherichia Coli
The author highlights novel strains and methods that have recently been shown to express multidisulfide bonded proteins. This article is part of a special section on expression systems.


BioPharm International
Volume 25, Issue 5, pp. 48-54

CONCLUSION

It has been two decades since the discovery of enzymes responsible for the formation of disulfide bonds in E. coli (61). Although great progress in understanding the molecular mechanism of disulfide bond formation has been made, comparatively little progress has been achieved in engineering novel strains which can correctly express multidisulfide bonded proteins. This lack of progress is mainly due to the fact that a given solution for expressing a recombinant protein is usually not transferable to the next protein. Thus, for each protein the researcher must start from scratch to find the suitable expression strain and condition.

One bottleneck for the researcher is the limited number of strains available to express disulfide bonded proteins. Those few new strains along with tools and techniques to assist the researcher in expressing disulfide bonded proteins have been reviewed here. The author hopes that increased molecular understanding of disulfide bond formation will result in an increasing repertoire of novel strains that are capable of producing active soluble recombinant proteins.

MEHMET BERKMEN, PHD, is a staff scientist at New England Biolabs, 240 County RD, Ipswich, MA 01938-2723, tel. 978.380.7519,
.

REFERENCES

1. F. Baneye and M. Mujacic, Nat. Biotechnol. 22 (11) 1399–408 (2004).

2. M.J. Kerner et al., Cell 122 (2) 209–20 (2005).

3. J.W. Wong, S.Y. Ho, and P.J. Hogg, Mol. Biol. Evol. 2010.

4. T. Zhang, E. Bertelsen, and T. Alber, Nat. Struct. Biol. 1 (7) 434–8 (1994).

5. O.R. Siadat, BMC Biochem 7 p. 12 (2006).

6. L. Debarbieux and J. Beckwith, Jrnl. Bacteriol. 182 (3) 723–7 (2000).

7. C. Lee et al., Nat. Struct. Mol. Biol. 11 (12) 1179–85 (2004).

8. F.A. Alvarez and D. Georgellis, Methods Enzymol. 471 p. 205–226 (2010).

9. J.G. Kang et al., Embo. Jrnl. 18 (15) 4292–8 (1999).

10. W.A. Prinz et al., Jrnl. Biol. Chem. 272 (25) 15661–7 (1997).

11. H. Kadokura, H. and J. Beckwith, Embo. Jrnl. 21 (10) 2354–63 (2002).

12. H.H. Lin and L.Y. Tseng, Nucleic Acids Res., 38 p. W503–7 (2010).

13. R. Singh, Brief Funct. Genomic Proteomic. 7 (2) 157–72 (2008).

14. F. Ferre and P. Clote, Nucleic Acids Res., 33 p. W230–2 (2005).

15. M. Beeby et al., PLoS Biol. 3 (9) e309 (2005).

16. R.J. Dutton et al., Proc. Natl. Acad. Sci. USA 105 (33) 11933–8 (2008).

17. O. Emanuelsson et al., Nat. Protoc. 2 (4) 953–71 (2007).

18. L. Kal, A. Krogh, and E.L. Sonnhammer, Nucleic Acids Res., 35 p. W429–32 (2007).

19. M.A. Reott et al., Jrnl. Bacteriol. 191 (10) 3384–91 (2009).

20. S.R. Shouldice et al., Mol. Microbiol. 75 (1) 13–28 (2010).

21. M. Berkmen, D. Boyd, and J. Beckwith, "Disulfide Bond Formation in the Periplasm," in The Periplasm, M. Ehrmann, Ed. (ASM Press, Washington, DC, 2006). pp. 122–140.

22. F. Hatahet and L.W. Ruddock, Antioxid, Redox Signal 11 (11) 2807–50 (2009).

23. M. Depuydt, J. Messens, and J.F. Collet, Antioxid. Redox. Signal 15 (1) 49–66 (2011).

24. H. Kadokura and J. Beckwith, Antioxid. Redox Signal, 2010.

25. J.L. Pan and J.C. Bardwell, Protein Sci. 15 (10) 2217–27 (2006).

26. U. Grauschopt et al., Cell 83 (6) 947–55 (1995).

27. G. Jander, N.L. Martin, and J. Beckwith, Embo. Jrnl. 13 (21) 5121–7 (1994).

28. M. Bader et al., Cell 98 (2) 217–27 (1999).


blog comments powered by Disqus

ADVERTISEMENT

Moscow Hosts IFPMA Biosimilars Conference
May 17, 2013
AbbVie and Alvine Will Collaborate on Celiac Disease Therapy
May 15, 2013
FDA Issues Pharmacoepidemiologic Safety Study Guidance
May 14, 2013
USP Launches Initiative to Fight Counterfeit Drugs in Sub-Saharan Africa
May 13, 2013
Amgen Forms New Joint Venture to Commercialize Vectibix in China
May 13, 2013
Upcoming Conferences
UPCOMING CONFERENCES

Access Programs for Investigational and Pre-Launch Drugs
Philadelphia, PA | July 17-18, 2013
Request Brochure

Strategic Pipeline Planning & Portfolio Valuation
Philadelphia, PA | August 13-14, 2013
Request Brochure

MES 2013 - Forum on Manufacturing Execution Systems
Philadelphia, PA | August 14-15, 2013
Request Brochure

Mobile Innovation for the Life Sciences Industry
Philadelphia, PA | August 20-21, 2013
Request Brochure

See All Conferences >>

ADVERTISEMENT

Author Guidelines
FindPharma
Source: BioPharm International,
Click here